Home › Funds › MFS Investment Management › BSX
MFS Investment Management position in BSX
BOSTON SCIENTIFIC CORP · Health Care
MFS Investment Management reported holding 43,054,393 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$2.29B, representing 0.78% of its reported portfolio and ranking #22 among its reported holdings. MFS Investment Management has disclosed BSX holdings in 34 of the last 47 reported quarters, going back to Q1 2015.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How MFS Investment Management's BSX position evolved
MFS Investment Management first disclosed a stake in BSX in Q1 2015 at 1,042,321 shares (US$18.50B). Across 34 filings, MFS Investment Management increased the stake 16 time(s), trimmed it 16 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 43,054,393 shares valued at US$2.29B — an increase of 18,195,202 shares quarter over quarter.. Notable position changes include a 165% increase in Q4 2018, a 119% increase in Q1 2020, a 126% increase in Q2 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2015 | 1.04M | $18.50B | New |
| Q3 2018 | 3.00M | $115.62M | New |
| Q4 2018 | 7.94M | $280.77M | Add |
| Q1 2019 | 11.38M | $436.95M | Add |
| Q2 2019 | 11.60M | $498.78M | Add |
| Q3 2019 | 12.23M | $497.56M | Add |
| Q4 2019 | 13.58M | $614.21M | Add |
| Q1 2020 | 29.73M | $970.22M | Add |
| Q2 2020 | 43.02M | $1.51B | Add |
| Q3 2020 | 43.33M | $1.66B | Add |
| Q4 2020 | 49.03M | $1.76B | Add |
| Q1 2021 | 82.66M | $3.19B | Add |
| Q2 2021 | 84.42M | $3.61B | Add |
| Q3 2021 | 83.80M | $3.64B | Reduce |
| Q4 2021 | 85.53M | $3.63B | Add |
| Q1 2022 | 84.17M | $3.73B | Reduce |
| Q2 2022 | 83.61M | $3.12B | Reduce |
| Q3 2022 | 84.09M | $3.26B | Add |
| Q4 2022 | 81.98M | $3.79B | Reduce |
| Q1 2023 | 79.53M | $3.98B | Reduce |
| Q2 2023 | 69.14M | $3.74B | Reduce |
| Q3 2023 | 62.53M | $3.30B | Reduce |
| Q4 2023 | 57.18M | $3.31B | Reduce |
| Q1 2024 | 46.61M | $3.19B | Reduce |
| Q2 2024 | 31.79M | $2.45B | Reduce |
| Q3 2024 | 25.67M | $2.15B | Reduce |
| Q4 2024 | 19.66M | $1.76B | Reduce |
| Q1 2025 | 16.52M | $1.67B | Reduce |
| Q2 2025 | 12.86M | $1.38B | Reduce |
| Q3 2025 | 10.37M | $1.01B | Reduce |
| Q4 2025 | 9.09M | $866.31M | Reduce |
| Q1 2026 | 11.00M | $716.92M | Add |
| Q2 2026 | 24.86M | $1.50B | Add |
| Q3 2026 | 43.05M | $2.29B | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 17 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), D. E. Shaw & Co (US$1.16B), Janus Henderson Group (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- PRIMECAP MANAGEMENT CO/CA/ 58.62M sh · $2.56B · Q3 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
More on MFS Investment Management
FAQ
How long has MFS Investment Management held BSX?
MFS Investment Management has disclosed BSX holdings in 34 of the last 47 reported quarters, going back to Q1 2015.
What is MFS Investment Management's current position in BSX?
As of Q3 2026, MFS Investment Management holds 43.05M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $2.29B, representing 0.78% of its reported portfolio and ranking #22.
Has MFS Investment Management been buying or selling BSX?
In the latest 13F filing (Q3 2026), MFS Investment Management increased its position in BSX.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, Janus Henderson Group, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.